Image Technologies

Image Technologies Corporation is a biotechnology and medical diagnostics company specializing in the development of advanced optical imaging technologies for non-invasive biomarker measurement. Spun off from the University of Utah, the company pioneered the use of Resonance Raman Spectroscopy (RRS) and Autofluorescence Imaging (AFI) to quantify critical nutrients and metabolic byproducts in the human eye and skin. Its proprietary solutions are primarily used to assess macular pigment density, a key indicator for the risk and progression of age-related macular degeneration (AMD). The company's technology has been successfully commercialized through major partnerships, most notably with Pharmanex (a division of Nu Skin) for the BioPhotonic Scanner, which monitors antioxidant status in the skin. Image Technologies Corporation continues to support clinical research and diagnostic innovation in ophthalmology and nutritional science.